SG Capital Management LLC Makes New Investment in Ralliant Corporation $RAL

SG Capital Management LLC acquired a new position in shares of Ralliant Corporation (NYSE:RAL) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 186,120 shares of the company’s stock, valued at approximately $8,139,000. SG Capital Management LLC owned 0.17% of Ralliant at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of RAL. Dodge & Cox purchased a new position in shares of Ralliant in the 2nd quarter valued at about $523,571,000. Viking Global Investors LP purchased a new stake in shares of Ralliant in the 2nd quarter valued at approximately $257,200,000. State Street Corp acquired a new stake in shares of Ralliant in the 2nd quarter valued at $213,096,000. Flossbach Von Storch SE acquired a new stake in shares of Ralliant in the 2nd quarter valued at $198,077,000. Finally, Norges Bank purchased a new stake in shares of Ralliant during the 2nd quarter worth $108,453,000.

Trending Headlines about Ralliant

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Management reiterated outlook and highlighted share buybacks at recent conferences, which could support earnings per share over time and signal capital return discipline. Ralliant Highlights Outlook and Share Buybacks at Conferences
• Neutral Sentiment: Ralliant presented at the Barclays Industrial Select Conference (slides made public) — informational for investors but not materially new versus the company’s prior guidance. Ralliant Presents at Barclays Conference
• Negative Sentiment: Multiple law firms (Kaplan Fox, Schall, Kessler Topaz, Levi & Korsinsky) have announced investigations into Ralliant for potential securities-law violations or fraud tied to disclosures around the quarter. These actions increase legal risk, create potential follow‑on litigation and regulatory scrutiny, and are a major near‑term overhang on the stock. Kaplan Fox Investigation Alert Schall Law Firm Notice Kessler Topaz Notice
• Negative Sentiment: Levi & Korsinsky flagged a roughly $14-per-share divergence between adjusted EPS (which beat estimates) and GAAP EPS (a $12.10 loss), driven mainly by a $1.4 billion goodwill impairment disclosed in the Feb. 4 release. That accounting shock raises questions about prior impairment assessment, earnings quality, and management disclosure — the proximate cause of the investor and media scrutiny. Levi & Korsinsky Probe
• Negative Sentiment: Media coverage (local and national) is highlighting the size of the charge and the resulting fraud/probe headlines; negative press can amplify volatility and pressure the stock until legal or accounting issues are resolved. Hoodline Coverage

Insiders Place Their Bets

In other Ralliant news, Director Kevin E. Bryant bought 1,250 shares of Ralliant stock in a transaction on Friday, February 6th. The stock was bought at an average price of $39.97 per share, with a total value of $49,962.50. Following the completion of the acquisition, the director owned 4,653 shares in the company, valued at $185,980.41. The trade was a 36.73% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Anelise Angelino Sacks bought 2,000 shares of the firm’s stock in a transaction on Monday, February 9th. The shares were purchased at an average price of $41.25 per share, for a total transaction of $82,500.00. Following the completion of the transaction, the director owned 5,403 shares of the company’s stock, valued at $222,873.75. This represents a 58.77% increase in their position. The SEC filing for this purchase provides additional information. In the last quarter, insiders acquired 8,145 shares of company stock valued at $332,233.

Ralliant Price Performance

Shares of RAL opened at $43.98 on Thursday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.58 and a current ratio of 0.84. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $57.02. The firm has a 50-day simple moving average of $50.36 and a 200-day simple moving average of $46.52. The company has a market capitalization of $4.96 billion and a price-to-earnings ratio of 22.44.

Ralliant (NYSE:RAL) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.67 by $0.02. The company had revenue of $554.60 million for the quarter, compared to analysts’ expectations of $543.04 million. The firm’s revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Monday, March 9th. Ralliant’s dividend payout ratio is currently 10.20%.

Wall Street Analysts Forecast Growth

RAL has been the topic of a number of analyst reports. Vertical Research upgraded Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price target on the stock in a research note on Friday, February 6th. Royal Bank Of Canada lowered their price target on Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a report on Friday, February 6th. Morgan Stanley reiterated an “overweight” rating and issued a $45.00 price target on shares of Ralliant in a research note on Friday, February 6th. Oppenheimer reduced their price objective on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Finally, Citigroup dropped their target price on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $50.50.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.